1. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973; 55:1629–1632.
2. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am. 1977; 59:345–351.
Article
3. Della Valle AG, Ruzo PS, Pavone V, Tolo E, Mintz DN, Salvati EA. Heterotopic ossification after total hip arthroplasty: a critical analysis of the Brooker classification and proposal of a simplified rating system. J Arthroplasty. 2002; 17:870–875.
4. Neal B, Gray H, MacMahon S, Dunn L. Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg. 2002; 72:808–821.
Article
5. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969; 51:737–755.
Article
6. Ranganathan K, Loder S, Agarwal S, et al. Heterotopic ossification: basic-science principles and clinical correlates. J Bone Joint Surg Am. 2015; 97:1101–1111.
Article
7. Anthonissen J, Ossendorf C, Hock JL, et al. The role of muscular trauma in the development of heterotopic ossification after hip surgery: an animal-model study in rats. Injury. 2016; 47:613–616.
Article
8. Hierton C, Blomgren G, Lindgren U. Factors associated with heterotopic bone formation in cemented total hip prostheses. Acta Orthop Scand. 1983; 54:698–702.
Article
9. DeLee J, Ferrari A, Charnley J. Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop Relat Res. 1976; (121):53–59.
Article
10. Eggli S, Rodriguez J, Ganz R. Heterotopic ossification in total hip arthroplasty: the significance for clinical outcome. Acta Orthop Belg. 2000; 66:174–180.
11. Ekelund A, Brosjö O, Nilsson OS. Experimental induction of heterotopic bone. Clin Orthop Relat Res. 1991; (263):102–112.
Article
12. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg. 2004; 12:116–125.
Article
13. van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. Acta Orthop. 2007; 78:90–94.
Article
14. Freeman TA, Parvizi J, Dela Valle CJ, Steinbeck MJ. Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty. Fibrogenesis Tissue Repair. 2010; 3:17.
Article
15. Foster DE, Hunter JR. The direct lateral approach to the hip for arthroplasty. Advantages and complications. Orthopedics. 1987; 10:274–280.
Article
16. Bischoff R, Dunlap J, Carpenter L, DeMouy E, Barrack R. Heterotopic ossification following uncemented total hip arthroplasty. Effect of the operative approach. J Arthroplasty. 1994; 9:641–644.
17. Rath EM, Russell GV Jr, Washington WJ, Routt ML Jr. Gluteus minimus necrotic muscle debridement diminishes heterotopic ossification after acetabular fracture fixation. Injury. 2002; 33:751–756.
Article
18. Rama KR, Vendittoli PA, Ganapathi M, Borgmann R, Roy A, Lavigne M. Heterotopic ossification after surface replacement arthroplasty and total hip arthroplasty: a randomized study. J Arthroplasty. 2009; 24:256–262.
Article
19. Fransen M, Neal B, Cameron ID, et al. Determinants of heterotopic ossification after total hip replacement surgery. Hip Int. 2009; 19:41–46.
Article
20. Edwards DS, Barbur SA, Bull AM, Stranks GJ. Posterior mini-incision total hip arthroplasty controls the extent of postoperative formation of heterotopic ossification. Eur J Orthop Surg Traumatol. 2015; 25:1051–1055.
Article
21. Hedley AK, Mead LP, Hendren DH. The prevention of heterotopic bone formation following total hip arthroplasty using 600 rad in a single dose. J Arthroplasty. 1989; 4:319–325.
Article
22. Barthel T, Baumann B, Nöth U, Eulert J. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand. 2002; 73:611–614.
Article
23. Grohs JG, Schmidt M, Wanivenhaus A. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop. 2007; 78:95–98.
Article
24. Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol. 2000; 40:124–132.
Article
25. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005; 352:1092–1102.
Article
26. Sneath RJ, Bindi FD, Davies J, Parnell EJ. The effect of pulsed irrigation on the incidence of heterotopic ossification after total hip arthroplasty. J Arthroplasty. 2001; 16:547–551.
Article
27. Mellema J, Zijlstra W, van Raaij T, ten Have B, van Raay J. Pulsed lavage in cementless total hip arthroplasty reduces the incidence of brooker grade 3 and 4 heterotopic ossifications. Open Orthop J. 2011; 1:9–13.